O
OrbiMed’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-289,900
| Closed | -$32.9M | – | 115 |
|
|
2024
Q2 | $32.9M | Buy |
289,900
+149,600
| +107% | +$17M | 0.65% | 45 |
|
|
2024
Q1 | $19.5M | Buy |
140,300
+67,100
| +92% | +$9.31M | 0.36% | 66 |
|
|
2023
Q4 | $9.08M | Buy |
+73,200
| New | +$9.08M | 0.18% | 79 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 124 |
|
|
2022
Q2 | – | Sell |
-149,900
| Closed | -$76.7M | – | 140 |
|
|
2022
Q1 | $76.7M | Sell |
149,900
-3,000
| -2% | -$1.53M | 1.24% | 28 |
|
|
2021
Q4 | $82.1M | Sell |
152,900
-75,100
| -33% | -$40.3M | 1.06% | 33 |
|
|
2021
Q3 | $125M | Sell |
228,000
-69,400
| -23% | -$38M | 1.37% | 24 |
|
|
2021
Q2 | $127M | Hold |
297,400
| – | – | 1.28% | 24 |
|
|
2021
Q1 | $107M | Buy |
297,400
+18,300
| +7% | +$6.58M | 1% | 28 |
|
|
2020
Q4 | $103M | Buy |
279,100
+52,700
| +23% | +$19.5M | 0.9% | 31 |
|
|
2020
Q3 | $93.3M | Hold |
226,400
| – | – | 1.17% | 24 |
|
|
2020
Q2 | $91.8M | Sell |
226,400
-111,600
| -33% | -$45.2M | 1.29% | 25 |
|
|
2020
Q1 | $91M | Buy |
338,000
+103,100
| +44% | +$27.8M | 1.53% | 23 |
|
|
2019
Q4 | $51.4M | Sell |
234,900
-149,100
| -39% | -$32.6M | 0.73% | 43 |
|
|
2019
Q3 | $57.3M | Buy |
384,000
+121,100
| +46% | +$18.1M | 1.09% | 32 |
|
|
2019
Q2 | $39.4M | Buy |
262,900
+124,200
| +90% | +$18.6M | 0.61% | 48 |
|
|
2019
Q1 | $16.5M | Hold |
138,700
| – | – | 0.26% | 79 |
|
|
2018
Q4 | $16.6M | Buy |
+138,700
| New | +$16.6M | 0.31% | 72 |
|